Expression of microRNA-26b, an obesity-related microRNA, is regulated by free fatty acids, glucose, dexamethasone and growth hormone in human adipocytes

Mol Med Rep. 2014 Jul;10(1):223-8. doi: 10.3892/mmr.2014.2204. Epub 2014 May 2.

Abstract

MicroRNAs (miRNAs) are short non-coding RNAs that are involved in numerous biological processes, including obesity and insulin resistance. miR-26b is an obesity-related intronic miRNA located in the intron of the carboxy‑terminal domain, RNA polymerase II, polypeptide A, small phosphatase 1 gene. miR-26b is abundantly expressed in mice and mature human adipocytes, and is associated with the expression of adipokines. In the present study, the effects of energy-source materials and hormones associated with obesity, on miR-26b expression were investigated. It was demonstrated that free fatty acids (FFAs), glucose, glucocorticoids and growth hormone (GH) downregulate the expression of miR-26b in human adipocytes. The results indicate that the expression of miR-26b is affected by a variety of factors that are correlated with obesity and insulin sensitivity. Therefore, miR-26b may be an important mediator in the development of obesity‑associated insulin resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / cytology
  • Adipocytes / drug effects*
  • Adipocytes / metabolism
  • Cells, Cultured
  • Dexamethasone / pharmacology*
  • Fatty Acids, Nonesterified / pharmacology*
  • Gene Expression Regulation / drug effects
  • Glucose / pharmacology*
  • Growth Hormone / pharmacology*
  • Humans
  • Insulin Resistance
  • MicroRNAs / metabolism*
  • Obesity / genetics
  • Obesity / metabolism
  • Obesity / pathology
  • Time Factors

Substances

  • Fatty Acids, Nonesterified
  • MIRN26A microRNA, human
  • MicroRNAs
  • Dexamethasone
  • Growth Hormone
  • Glucose